Sinead Toomey

8PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersMolecular targetsScreen media
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer.

Nicola Cosgrove, Alex J Eustace, Peter O'Donovan

|Jun 16, 2023
Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer.

Cha Len Lee, Mattia Cremona, Angela Farrelly

|Jan 10, 2022
COVID-19 contamination of high-touch surfaces in the public domain.

Niall T Hennessy, Sinead Toomey, Virginie Gautier

|May 02, 2021
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer.

M Janusz Mezynski, Angela M Farrelly, Mattia Cremona

|Oct 30, 2020
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.

Denis M Collins, Stephen F Madden, Nicola Gaynor

|Feb 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.

Sinead Toomey, Aoife Carr, Mateusz Janusz Mezynski

Pageof 2